Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease.

Literature DB >> 27132257

Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease.

Ian D Pavord¹, Alvar Agusti².

Abstract

Entities: Disease Species

Mesh：

Substances：
Biomarkers

Year: 2016 PMID： 27132257 DOI： 10.1183/13993003.00055-2016

Source DB: PubMed Journal: Eur Respir J ISSN： 0903-1936 Impact factor: 16.671

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. Prediction of non-muscle-invasive bladder cancer recurrence during intravesical BCG immunotherapy by use of peripheral blood eosinophil count and percentage: a preliminary report.

Authors: Mustafa Zafer Temiz; Aykut Colakerol; Ismail Ulus; Enes Kilic; Filip Paslanmaz; Sergen Sahin; Emrah Yuruk; Engin Kandirali; Atilla Semercioz; Ahmet Yaser Muslumanoglu
Journal: Cancer Immunol Immunother Date: 2020-07-22 Impact factor: 6.968

Review 2. What will Happen in the World of COPD 2030?

Authors: Richard E K Russell; Mona Bafadhel
Journal: Turk Thorac J Date: 2019-07-30

3. An association between pulmonary Mycobacterium avium-intracellulare complex infections and biomarkers of Th2-type inflammation.

Authors: Paul E Pfeffer; Susan Hopkins; Ian Cropley; David M Lowe; Marc Lipman
Journal: Respir Res Date: 2017-05-15

4. Inhaled treatment of COPD: a Delphi consensus statement.

Authors: Vincent Ninane; Jean-Louis Corhay; Paul Germonpré; Wim Janssens; Guy F Joos; Giuseppe Liistro; Walter Vincken; Sandra Gurdain; Evelyne Vanvlasselaer; An Lehouck
Journal: Int J Chron Obstruct Pulmon Dis Date: 2017-03-06

5. Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality.

Authors: Olorunfemi A Oshagbemi; Frits M E Franssen; Dionne C W Braeken; Yvonne Henskens; Emiel F M Wouters; Anke-Hilse Maitland-van der Zee; Andrea M Burden; Frank de Vries
Journal: Pharmacoepidemiol Drug Saf Date: 2018-09-28 Impact factor: 2.890

6. Blood eosinophil count as a prognostic biomarker in COPD.

Authors: Yeon-Mok Oh; Keu Sung Lee; Yoonki Hong; Sung Chul Hwang; Jae Yeol Kim; Deog Keom Kim; Kwang Ha Yoo; Ji-Hyun Lee; Tae-Hyung Kim; Seong Yong Lim; Chin Kook Rhee; Hyoung Kyu Yoon; Sang Yeub Lee; Yong Bum Park; Jin Hee Jung; Woo Jin Kim; Sang-Do Lee; Joo Hun Park
Journal: Int J Chron Obstruct Pulmon Dis Date: 2018-10-31

Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease.

1. Prediction of non-muscle-invasive bladder cancer recurrence during intravesical BCG immunotherapy by use of peripheral blood eosinophil count and percentage: a preliminary report.

Review 2. What will Happen in the World of COPD 2030?

3. An association between pulmonary Mycobacterium avium-intracellulare complex infections and biomarkers of Th2-type inflammation.

4. Inhaled treatment of COPD: a Delphi consensus statement.

5. Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality.

6. Blood eosinophil count as a prognostic biomarker in COPD.

7. Factors that affect blood eosinophil counts in a non-asthmatic population: Post hoc analysis of data from Brazil.

Review 8. Identification of Asthma Subtypes Using Clustering Methodologies.

Review 9. Role of biologics in severe eosinophilic asthma - focus on reslizumab.

10. Characteristics of Treated Asthmatics Experiencing Exacerbations in a US Database: A Retrospective Cohort Study.